Skip to main content
Log in

Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Objective

The purpose of the present study was to evaluate the usefulness of coronal reformatted images obtained from 64-slice multi-detector computed tomography to assess the ablative margin (AM) in hepatocellular carcinoma (HCC) treated with radio frequency ablation (RFA).

Methods

Ninety-five HCC nodules were analyzed in 66 HCC patients treated with RFA. Two radiologists and one hepatologist independently reviewed axial CT images with or without coronal reformatted images in HCC treated with RFA. Nodules were determined as AM-sufficient (≥5 mm) or AM-insufficient (<5 mm). The level of interobserver agreement was measured using the weighted kappa test. The sensitivity, specificity, and positive and negative predictive values (NPVs) of an insufficient AM (<5 mm) to predict local recurrence were evaluated.

Results

The numbers of AM-sufficient nodules judged by readers 1–3 based on axial images and both axial and coronal images were 56, 49, and 58, and 47, 33, and 48, respectively. Excellent agreement and good to excellent agreement were obtained among the three readers on axial image readings and both axial and coronal image readings, respectively. The mean sensitivity, specificity, and positive and NPVs of an insufficient AM on axial images and both axial and coronal images to predict local recurrence were 64%, 60%, 17%, and 93%, and 95%, 50%, 20%, and 97%, respectively.

Conclusions

Coronal reformatted CT images should be utilized to evaluate the AM in HCC treated with RFA in order to decrease the risk of local recurrence following treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576

    Article  CAS  PubMed  Google Scholar 

  2. Cho YK, Kim JK, Kim MY, et al. (2009) Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 49:453–459

    Article  PubMed  Google Scholar 

  3. Garrean S, Hering J, Saied A, et al. (2008) Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 195:508–520

    Article  PubMed  Google Scholar 

  4. Park MH, Rhim H, Kim YS, et al. (2008) Spectrum of CT findings after radiofrequency ablation of hepatic tumors. Radiographics 28:379–390

    Article  PubMed  Google Scholar 

  5. Barker DW, Zagoria RJ, Morton KA, et al. (2005) Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CT. AJR Am J Roentgenol 184:1096–1102

    Article  PubMed  Google Scholar 

  6. Schraml C, Clasen S, Schwenzer NF, et al. (2008) Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases. Abdom Imaging 33:643–651

    Article  PubMed  Google Scholar 

  7. Yanaga Y, Awai K, Nakaura T, et al. (2008) Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT. AJR Am J Roentgenol 190:1003–1009

    Article  PubMed  Google Scholar 

  8. Marin D, Catalano C, De Filippis G, et al. (2009) Detection of hepatocellular carcinoma in patients with cirrhosis: added value of coronal reformations from isotropic voxels with 64-MDCT. AJR Am J Roentgenol 192:180–187

    Article  PubMed  Google Scholar 

  9. Bruix J, Sherman M (2011) American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

    Article  PubMed Central  PubMed  Google Scholar 

  10. Tateishi R, Shiina S, Teratani T, et al. (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201–1209

    Article  PubMed  Google Scholar 

  11. Shiina S, Teratani T, Obi S, et al. (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122–130

    Article  PubMed  Google Scholar 

  12. Tokunaga S, Koda M, Matono T, et al. (2012) Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT. Br J Radiol 85:745–752

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Inoue T, Kudo M, Hatanaka K, et al. (2013) Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT. Oncology 84(Suppl 1):51–57

    Article  PubMed  Google Scholar 

  14. Tomonari A, Tsuji K, Yamazaki H, et al. (2013) Feasibility of fused imaging for the evaluation of radiofrequency ablative margin for hepatocellular carcinoma. Hepatol Res 43:728–734

    Article  PubMed  Google Scholar 

  15. Kim KW, Lee JM, Klotz E, et al. (2011) Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images. AJR Am J Roentgenol 196:W565–W572

    Article  PubMed  Google Scholar 

  16. Koda M, Tokunaga S, Miyoshi K, et al. (2012) Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol 81:2730–2736

    Article  PubMed  Google Scholar 

  17. Lee EY, Zucker EJ, Tsai J, et al. (2011) Pulmonary MDCT angiography: value of multiplanar reformatted images in detecting pulmonary embolism in children. AJR Am J Roentgenol 197:1460–1465

    Article  PubMed  Google Scholar 

  18. Tsili AC, Argyropoulou MI, Gousia A, et al. (2012) Renal cell carcinoma: value of multiphase MDCT with multiplanar reformations in the detection of pseudocapsule. AJR Am J Roentgenol 199:379–386

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Dr. Fumihiko Kanai (Medical Corporation Eikenkai) for the valuable discussions.

Conflict of interest

There is no conflict of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tetsuhiro Chiba.

Additional information

Tenyu Motoyama and Sadahisa Ogasawara contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Motoyama, T., Ogasawara, S., Chiba, T. et al. Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma. Abdom Imaging 39, 262–268 (2014). https://doi.org/10.1007/s00261-013-0054-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-013-0054-0

Keywords

Navigation